COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 16: Articles 151-160  | Next

Beyond the blood: Tissue-resident immunity shapes SARS-CoV-2 vaccine antibody responses
Schröter, J., van Dorp, C. H., Davis-Porada, J., Teijaro, J. R., Farber, D. L., Yates, A. J.
10.64898/2026.07.23.740375 — Posted: 2026-07-24
SARS-CoV-2 nucleocapsid protein engages with viral RNA and ERGIC lipids to drive viral core assembly
Swarnakar, S., Mishra, J., Rat, V., Merida, P., Bunel, L., Avinens, D., Feuillard, J., Lyonnais, S., Martinez, E., Swain, J., Dufourt, J., Blaise, M., Favard, C., Basu, J. K., Muriaux, D.
10.64898/2026.07.23.740351 — Posted: 2026-07-23
Epigenetic Regulation of Stable SARS-CoV-2 RBD-sfGFP Expression in Primary Human Splenic Fibroblasts
Maan, K. S., Baloch, Z. A., Bhullar, S. S., Vashishat, I., Assogba, B. D.
10.64898/2026.07.22.739919 — Posted: 2026-07-23
Antibody evasion and receptor binding of SARS-CoV-2 variants PQ.16.1.1 and RK.1
He, P., Song, Y., Guo, C., Yu, L., Yu, Y., Jian, F., Shao, F., Cao, Y.
10.64898/2026.07.21.739818 — Posted: 2026-07-23
IFNγ at the crossroads of systemic protection and brain vulnerability to coronavirus infection
Sabater, A., Arevalo, A. P., Perbolianachis, P., Sanchis, P., Pascual, G., Porfido, J. L., Seniuk, R., Portela, M., Valacco, M. P., Cotignola, J., Vazquez, E., Labanca, E., Carballeda, J. M., Moreno, P., Moratorio, G., Crispo, M., Gueron, G., Toro, A.
10.64898/2026.07.17.739144 — Posted: 2026-07-23
Localized Rigidification and Allosteric Modulation Mechanisms of SARS-CoV-2 Spike Neutralization by Class 3 and Class 4 Antibodies at Atomic Resolution: An Integrated Computational Study of Binding, Dynamics, and Allostery
Alshahrani, M., Gatlin, W., Ludwick, M., Turano, L., Foley, B., Verkhivker, G.
10.64898/2026.07.12.738055 — Posted: 2026-07-21
A historical cross-border Andes virus lineage reveals the origin of a cruise ship hantavirus pulmonary syndrome outbreak
Ramos, H., Diaz-Gavidia, C., Diaz-Ramirez, D., Fuentes-Luppichini, E., Kuhn, J. H., Bellomo, C. M., Schüller, A., Araya-Secchi, R., International Genomics Consortium Investigating the M/V Hondius Outbreak, , Cisterna, D. M., Fernandez-Bettelli, L., Palacios-Aliggi, S., Martinez, V. P., Ferres, M., Maes, P., Palacios, G., Tischler, N. D., Angulo, J.
10.64898/2026.07.19.739363 — Posted: 2026-07-21
Coronavirus papain-like protease antagonizes innate immunity by cleaving Importin α1 to disrupt nuclear transport
Liao, Y., Wang, J., Xue, W., Sun, Y., Tan, L., Song, C., Qiu, X., Ding, C.
10.64898/2026.07.17.739146 — Posted: 2026-07-20
A human monoclonal antibody from hybrid immunity exhibits exceptional neutralization breadth against antigenically divergent contemporary Omicron JN.1 lineage variants
Rathour, D., Shrivas, S., Kumar, N., Prasad, C., Singh, J., Singh, G., Surendranath, A., Rathi, S., Verma, S., Chauhan, S., Singh, B., Sutar, J., Chattopadhyay, S., Batra, G., Sonar, S., Eckerle, I., Subbissi, L., Mohan, A., Asthana, S., Deshpande, S., BHATTACHARYA, J.
10.64898/2026.07.20.739483 — Posted: 2026-07-20
Variant-specific spike conformational dynamics shape memory B cell selection during recall
Broutin, M., Sokal, A., Dejoux, A., Planas, D., Vanderkerken, M., Fernandez, I., Azzaoui, I., Vandenberghe, A., Charlet, M., Arbabian, A., Megret, J., Toure, L., Planchais, C., Berard, L., Simon, T., Weill, J.-C., Mouquet, H., Schwartz, O., Bruhns, P., Rey, F. A., Launay, O., Mahevas, M., Chappert, P.
10.64898/2026.07.18.739204 — Posted: 2026-07-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).